AUROPHARMA - Aurobindo Pharma

Aurobindo Pharma

AUROPHARMA · Pharma > Pharmaceuticals & Drugs · Chairman: K Ragunathan · MD: N Govindarajan · Listing date: June 14, 1995 · Employees: 19364 · Hyderabad · http://www.aurobindo.com

Stock Price vs Company Growth

0.8%

0.3%

6.8%

7.9%

38.2%

50.2%

18.5%

10y

8.6%

all

18.0%

🤔 How to analyze this graph?

Last Traded Price

₹ 1,638 0.8%

1,391

1,682

Company Overview

Sales

34,935 Cr

Growth: 6.9%

Profit after Tax

3,713 Cr

Growth: 5.9%

Large Cap

94,227 Cr

P/E: 25.6x

Industry P/E: 31.7x

Fundamentals

Sales (Cr)	₹ 34,935
Growth	6.9%
EBITDA	20.3%
P/S	2.7x
Dividend	0.4%
P/E	25.6x
Book Value	₹ 676
PEG Ratio	3.7x
ROE	10.1%
P/B	2.4x

Shareholding Pattern

Institutions

Life Insurance Corporation Of India

3.46 %

Hdfc Trustee Company Limited-Hdfc Flexi Cap Fund

3.4 %

Qualified Institutional Buyer

1.95 %

Nippon Life India Trustee Ltd-A/C Nippon India Pharma Fund

1.32 %

Bnp Paribas Arbitrage

1.22 %

Promoters

Rpr Sons Advisors Private Limited, Mrs.P.Suneela Rani (Jointly Holding)

33.51 %

K Nityananda Reddy

4.33 %

Kirthi Reddy Kambam

3.49 %

Venkata Ramprasad Reddy Penaka

3.07 %

Axis Clinicals Limited, Trident Chemphar Limited, Rpr Sons Advisors Pvt.Ltd. (Jointly Holding)

2.85 %

Others

Increase Decrease No change

Company Profile Detailed

Aurobindo Pharma is one of the leading vertically integrated formulations & API manufacturing companies in the world. It has a strong R&D focus and has a multi-product portfolio with manufacturing facilities in several countries. The company operates diversified businesses, structured to deliver targeted healthcare solutions across geographies and therapeutic areas. Its core operations are built on strong, integrated capabilities, encompassing both APIs and finished products.

Belongs to (47 Indices) view more

Investors (197)

aditya.b...

hdfc.tru...

Followers (74)

nitin2

keerthi

deepak